| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.7M | — | +106.4% |
| Cost of Revenue | $17.6M | — | +105.6% |
| Gross Profit | $12.1M | — | +107.6% |
| R&D Expense | $8.2M | — | +38.0% |
| SG&A Expense | $15.2M | — | +168.4% |
| Operating Income | -$64.5M | — | -54.0% |
| Pre-tax Income | -$69.7M | — | -172.9% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$69.7M | — | -175.2% |
| EPS (Basic) | -$0.34 | — | -183.3% |
| EPS (Diluted) | -$0.34 | — | -183.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $355.3M | +73.6% | -27.1% |
| Accounts Receivable | $22.7M | -12.8% | — |
| Inventory | $31.7M | -3.6% | — |
| Current Assets | $505.4M | -3.9% | — |
| Total Assets | $573.2M | -10.2% | — |
| Current Liabilities | $56.1M | +6.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.1M | — | +5.3% |
| Capital Expenditures | $167K | — | -43.4% |
| Investing Cash Flow | $157.5M | — | -11.1% |
| Financing Cash Flow | -$41K | — | -17.1% |
| Free Cash Flow | -$7.2M | — | +6.8% |
| — |
| Total Liabilities | $87.8M | +1.8% | — |
| Stockholders' Equity | $485.4M | -12.1% | -41.9% |